Page last updated: 2024-11-02

phenylbutazone and Fibrous Dysplasia of Bone

phenylbutazone has been researched along with Fibrous Dysplasia of Bone in 1 studies

Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.

Fibrous Dysplasia of Bone: A disease of bone marked by thinning of the cortex by fibrous tissue containing bony spicules, producing pain, disability, and gradually increasing deformity. Only one bone may be involved (FIBROUS DYSPLASIA, MONOSTOTIC) or several (FIBROUS DYSPLASIA, POLYOSTOTIC).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cohrs, U1
Hauswaldt, C1
Hunstein, W1

Other Studies

1 other study available for phenylbutazone and Fibrous Dysplasia of Bone

ArticleYear
[The modification of experimental bone marrow fibrosis after repeated administration of foreign proteins by antiphlogistics and prednisolone acetate].
    Blut, 1969, Volume: 19, Issue:7

    Topics: Anaphylaxis; Animals; Anti-Inflammatory Agents; Blood Cell Count; Blood Platelets; Body Weight; Bone

1969